BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7581163)

  • 1. Radiolabeled metabolites of proteins play a critical role in radioactivity elimination from the liver.
    Arano Y; Mukai T; Akizawa H; Uezono T; Motonari H; Wakisaka K; Kairiyama C; Yokoyama A
    Nucl Med Biol; 1995 Jul; 22(5):555-64. PubMed ID: 7581163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Species difference in radioactivity elimination from liver parenchymal cells after injection of radiolabeled proteins.
    Mukai T; Arano Y; Nishida K; Sasaki H; Akizawa H; Ogawa K; Ono M; Saji H; Nakamura J
    Nucl Med Biol; 1999 Apr; 26(3):281-9. PubMed ID: 10363799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A biological method to evaluate bifunctional chelating agents to label antibodies with metallic radionuclides.
    Arano Y; Mukai T; Uezono T; Wakisaka K; Motonari H; Akizawa H; Taoka Y; Yokoyama A
    J Nucl Med; 1994 May; 35(5):890-8. PubMed ID: 8176478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stability of a metabolizable ester bond in radioimmunoconjugates.
    Arano Y; Wakisaka K; Mukai T; Uezono T; Motonari H; Akizawa H; Kairiyama C; Ohmomo Y; Tanaka C; Ishiyama M; Sakahara H; Konishi J; Yokoyama A
    Nucl Med Biol; 1996 Feb; 23(2):129-36. PubMed ID: 8868284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disposition of radioactivity after injection of liver-targeted proteins labeled with 111In or 125I. Effect of labeling on distribution and excretion of radioactivity in rats.
    Staud F; Nishikawa M; Morimoto K; Takakura Y; Hashida M
    J Pharm Sci; 1999 Jun; 88(6):577-85. PubMed ID: 10350492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic models to evaluate radiolabeling reagents for protein radiopharmaceuticals.
    Mukai T; Arano Y; Nishida K; Sasaki H; Nakamura J; Saji H; Yokoyama A
    Nucl Med Biol; 1998 Jan; 25(1):31-6. PubMed ID: 9466359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparative studies of 111In-labeled monoclonal antibody using spacer-containing and non-spacer bifunctional chelates: (II). Biodistribution, metabolism and excretion in vivo].
    Sun B
    Kaku Igaku; 1994 May; 31(5):473-87. PubMed ID: 8028219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bis(hydroxamamide)-based bifunctional chelating agent for 99mTc labeling of polypeptides.
    Xu LC; Nakayama M; Harada K; Kuniyasu A; Nakayama H; Tomiguchi S; Kojima A; Takahashi M; Ono M; Arano Y; Saji H; Yao Z; Sakahara H; Konishi J; Imagawa Y
    Bioconjug Chem; 1999; 10(1):9-17. PubMed ID: 9893958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative studies of 111In-labeled monoclonal antibody using spacer-containing and non-spacer bifunctional chelates: (I). Conjugation, labeling, immunoreactivity and in vitro stability].
    Sun B
    Kaku Igaku; 1994 May; 31(5):459-71. PubMed ID: 8028218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of the hepatic radioactivity levels of [
    Suzuki H; Matsukawa M; Madokoro R; Terasaka Y; Kannaka K; Uehara T
    Nucl Med Biol; 2024; 132-133():108910. PubMed ID: 38636351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of the radiochemical design of antibodies with a metabolizable linkage for target-selective radioactivity delivery.
    Arano Y; Wakisaka K; Akizawa H; Ono M; Kawai K; Nakayama M; Sakahara H; Konishi J; Saji H
    Bioconjug Chem; 1998; 9(4):497-506. PubMed ID: 9667952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maleimidoethyl 3-(tri-n-butylstannyl)hippurate: a useful radioiodination reagent for protein radiopharmaceuticals to enhance target selective radioactivity localization.
    Arano Y; Wakisaka K; Ohmomo Y; Uezono T; Mukai T; Motonari H; Shiono H; Sakahara H; Konishi J; Tanaka C
    J Med Chem; 1994 Aug; 37(16):2609-18. PubMed ID: 8057303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of radiochemical design of antibodies using an ester bond as the metabolizable linkage: evaluation of maleimidoethyl 3-(tri-n-butylstannyl)hippurate as a radioiodination reagent of antibodies for diagnostic and therapeutic applications.
    Arano Y; Wakisaka K; Ohmono Y; Uezono T; Akizawa H; Nakayama M; Sakahara H; Tanaka C; Konishi J; Yokoyama A
    Bioconjug Chem; 1996; 7(6):628-37. PubMed ID: 8950481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic evaluation of biodistribution data obtained with radiolabeled proteins in mice.
    Nishikawa M; Staud F; Takemura S; Takakura Y; Hashida M
    Biol Pharm Bull; 1999 Feb; 22(2):214-8. PubMed ID: 10077446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel radioiodination reagent for protein radiopharmaceuticals with L-lysine as a plasma-stable metabolizable linkage to liberate m-iodohippuric acid after lysosomal proteolysis.
    Wakisaka K; Arano Y; Uezono T; Akizawa H; Ono M; Kawai K; Ohomomo Y; Nakayama M; Saji H
    J Med Chem; 1997 Aug; 40(16):2643-52. PubMed ID: 9258371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of a peptide linker on biodistribution and metabolism of antibody-conjugated benzyl-EDTA. Comparison of enzymatic digestion in vitro and in vivo.
    Studer M; Kroger LA; DeNardo SJ; Kukis DL; Meares CF
    Bioconjug Chem; 1992; 3(5):424-9. PubMed ID: 1420442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A bifunctional HBED-derivative for labeling of antibodies with 67Ga, 111In and 59Fe. Comparative biodistribution with 111In-DPTA and 131I-labeled antibodies in mice bearing antibody internalizing and non-internalizing tumors.
    Schuhmacher J; Klivényi G; Hull WE; Matys R; Hauser H; Kalthoff H; Schmiegel WH; Maier-Borst W; Matzku S
    Int J Rad Appl Instrum B; 1992 Nov; 19(8):809-24. PubMed ID: 1428911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New method for the chelation of indium-111 to monoclonal antibodies: biodistribution and imaging of athymic mice bearing human colon carcinoma xenografts.
    Esteban JM; Schlom J; Gansow OA; Atcher RW; Brechbiel MW; Simpson DE; Colcher D
    J Nucl Med; 1987 May; 28(5):861-70. PubMed ID: 3106595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism of indium chelates attached to monoclonal antibody: minimal transchelation of indium from benzyl-EDTA chelate in vivo.
    Deshpande SV; Subramanian R; McCall MJ; DeNardo SJ; DeNardo GL; Meares CF
    J Nucl Med; 1990 Feb; 31(2):218-24. PubMed ID: 2107283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of metabolism on retention of indium-111-labeled monoclonal antibody in liver and blood.
    Kinuya S; Jeong JM; Garmestani K; Saga T; Camera L; Brechbiel MW; Gansow OA; Carrasquillo JA; Neumann RD; Paik CH
    J Nucl Med; 1994 Nov; 35(11):1851-7. PubMed ID: 7965168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.